East London: The ideal location for medical research
The Royal London Hospital in Whitechapel is an ideal location for the new Facility. It has excellent transport links, a concentration of research and clinical expertise, and a local population with challenging health needs who will benefit from new treatments and therapies.
East London has a more diverse population than the UK as a whole. Yet most clinical trials in the UK focus on the national majority. This is problematic for East Londoners, as it means clinical trials typically involve cohorts who are white, affluent and middle-aged. It means many people in our community – for reasons connected with ethnic background, age and circumstance – benefit less from the results of the studies than other areas of the UK.
A new Clinical Research Facility: our vision
- Our local populations will be better represented in important trials, including those living with long-term conditions like diabetes, kidney, heart and liver disease, and rheumatoid arthritis – with the goal of developing tailored and relevant interventions.
- Patients will benefit from the new Facility, since those taking part in clinical trials generally have better experiences and outcomes than those who receive standard care packages. It will also bring greater benefit to the wider population through the earlier translation of research into clinical practice.
- Vastly improved trial facilities with large laboratories and room for patients to stay overnight will enable the hospital to be part of more important studies, with research partners knowing their trials can be seen through from beginning to end.
- More commercial opportunities for successful partnerships will be created by building a truly world-class Facility. Life Sciences and general clinical research is a burgeoning industry, with new opportunities in traditional drugs trials, novel technologies, remote monitoring, genetics and medical devices.
- The world’s best scientists will be attracted to East London by offering world-class facilities that attract world-class trials. This will bring enhanced reputation and recruitment opportunities for our partners at Barts Health and Queen Mary University of London.
Maximising research opportunities
As one of the largest NHS Trusts in the country, Barts Health is already seen as a leader in research and there are opportunities to extend the volume and range of research activity.
Now it’s time to make the most of these opportunities to attract increased funding, recruit the world’s best researchers, and ensure the diversity of our community is represented in future trials.